What does full approval of Pfizer’s COVID-19 vaccine mean?

Advertisement

Advertise with us

What does full approval of Pfizer’s COVID-19 vaccine mean?

Read this article for free:


or

Already have an account? Log in here »

To continue reading, please subscribe:

Subscribe and receive a limited-edition Free Press branded hat or tote.

Digital Subscription

One year of digital access for only $205*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 23/08/2021 (1869 days ago), so information in it may no longer be current.

What does full approval of Pfizer’s COVID-19 vaccine mean?

It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other long-established vaccines.

COVID-19 vaccines in the U.S. were initially rolled out under the Food and Drug Administration’s emergency use authorization, which allows the agency to speed the availability of medical products during public health emergencies.

What changed with the full approval of Pfizer’s COVID-19 vaccine? (AP Illustration/Peter Hamlin)
What changed with the full approval of Pfizer’s COVID-19 vaccine? (AP Illustration/Peter Hamlin)

Under the process, the FDA waived some of its normal data requirements and procedures to make the COVID-19 vaccines available months earlier than would have been possible under normal circumstances.

Pfizer’s vaccine — along with those from Moderna and Johnson & Johnson — still underwent testing in tens of thousands of people to establish safety and effectiveness against COVID-19. But the FDA initially required the companies to submit about only two months of safety monitoring data on study participants, the period when side effects are most likely to occur.

For full approval, the FDA required six months of follow-up data. FDA inspectors also visited the plants where the vaccines are made and reviewed each step of the production process for extra assurance that the shots are made under safe, sterile conditions.

Because vaccines are typically given to otherwise healthy individuals, they are generally subject to more regulatory scrutiny than other medical products, including prescription drugs. Full approval means the Pfizer vaccine now carries the FDA’s strongest endorsement of safety and effectiveness.

Public health experts hope the change will convince more unvaccinated people to get the shot and spur more employers to require vaccinations.

Moderna has also applied for full approval, and Johnson & Johnson has said it hopes to apply later in the year.

Pfizer’s shot still is available for 12- to 15-year-olds under emergency use authorization. The full approval also doesn’t apply to boosters. The agency will decide separately whether an extra shot is necessary for healthy people.

___

The AP is answering your questions about the coronavirus in this series. Submit them at: FactCheck@AP.org. Read more here:

Do I need a booster if I got the Johnson & Johnson vaccine?

Do the COVID-19 vaccines affect my chances of pregnancy?

Can I get ‘long COVID’ if I’m infected after vaccination?

Report Error Submit a Tip

More Stories

‘Amazing honour’: Winnipeg distribution centre continues award-winning ways for McKesson Canada

Aaron Epp 5 minute read Preview

‘Amazing honour’: Winnipeg distribution centre continues award-winning ways for McKesson Canada

Aaron Epp 5 minute read 6:00 AM CDT

After a three-year absence, the trophy is back in Winnipeg.

Last week, McKesson Canada named its 120,000-square-foot pharmaceutical distribution centre in the northwest part of the Manitoba capital its Distribution Centre of the Year. The award recognizes the facility’s role in helping essential medications reach communities across the province and some of Canada’s remote regions.

This is the fourth time the Winnipeg facility has earned the company-wide award since it opened five years ago. McKesson previously honoured the centre in 2021, 2022 and 2023. The recognition comes with a trophy, as well as a banner that was hung from the rafters on Thursday.

More than 100 employees work across the centre’s day-and-night operations, processing between 80,000 and 100,000 medication units daily. Last year, the centre distributed more than 21 million medication units while maintaining more than 99 per cent accuracy.

Read
6:00 AM CDT

Stevenson set for first Jets start against Penguins

Ken Wiebe 5 minute read Preview

Stevenson set for first Jets start against Penguins

Ken Wiebe 5 minute read Yesterday at 6:55 PM CDT

DETROIT — Clay Stevenson, the stage is yours.

As the Winnipeg Jets wrap up a two-game road trip on Monday against the Pittsburgh Penguins, the newest member of the team will be between the pipes after Stuart Skinner got the call in the first two outings of the campaign.

There will be an element of familiarity for Stevenson, as PPG Paints Arena is where he made his first NHL appearance with the Washington Capitals on April 17, 2025.

“There is some comfortability in that building,” said Stevenson, who made 33 saves in a 5-2 loss to the Penguins in that NHL debut. “It’s always a great challenge to play against (Sidney) Crosby and (Evgeni) Malkin and those guys. It’s an honour to get into the crease anytime.”

Read
Yesterday at 6:55 PM CDT

Six high school hockey programs ceased operations following new Hockey Manitoba policy

Joshua Frey-Sam 7 minute read Preview

Six high school hockey programs ceased operations following new Hockey Manitoba policy

Joshua Frey-Sam 7 minute read Friday, Oct. 2, 2026

She lived the best of both worlds.

For the last three years, the 17-year-old wore a sweater for two different hockey programs — her high school team and AAA club in the Manitoba Female Hockey League — and was preparing to flourish in both colours again this winter.

Recently, however, the blue-liner was disappointed to learn she is no longer eligible to play her Grade 12 season with her school owing to a new policy imposed by Hockey Manitoba that bans players from participating in the Manitoba Women’s High School Hockey League if they are rostered on a U18 AAA team.

The rule applies to all athletes who play for both Winnipeg-based and rural AAA teams.

Read
Friday, Oct. 2, 2026

Wasteful operations should be held accountable

Barry E. Prentice 5 minute read Preview

Wasteful operations should be held accountable

Barry E. Prentice 5 minute read 2:00 AM CDT

Rising water bills are a top-of-mind issue for residents of Winnipeg going into the fall election. Management of the water and waste system is under question, with citizen’s groups, as well as the Free Press, calling for proper oversight of rates.

Read
2:00 AM CDT

Broadening prediction-market gambling a bad idea

Editorial 4 minute read Preview

Broadening prediction-market gambling a bad idea

Editorial 4 minute read Saturday, Oct. 3, 2026

Let’s make a prediction: sooner or later, when Canadian governments find a way to take their own cut of the action, prediction-contract gambling on everything from sports to entertainment to political decisions is going to come to Canada.

And that’s a horrible, dangerous, pernicious idea.

Unless you have particular access to information — either inside information or strategic information based on skills or education — you’re not likely to make money at it. In fact, structurally, you’re likely to lose. In prediction markets, you basically pay an amount, plus fees from the company involved, to bet on whether something will or will not happen within a certain time frame. The amount you pay for your contract depends on how other people are also betting.

As Wealthsimple describes it, “You buy whichever side you think is right. Prices move with demand, so if the market leans towards one outcome, the more that side costs. If a lot of people are backing the TSX to finish above 38,000, yes gets more expensive and no gets cheaper.”

Read
Saturday, Oct. 3, 2026

What does full approval of Pfizer’s COVID-19 vaccine mean?

Matthew Perrone, The Associated Press 3 minute read Preview

What does full approval of Pfizer’s COVID-19 vaccine mean?

Matthew Perrone, The Associated Press 3 minute read Monday, Aug. 23, 2021

What does full approval of Pfizer’s COVID-19 vaccine mean?

It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other long-established vaccines.

COVID-19 vaccines in the U.S. were initially rolled out under the Food and Drug Administration's emergency use authorization, which allows the agency to speed the availability of medical products during public health emergencies.

Under the process, the FDA waived some of its normal data requirements and procedures to make the COVID-19 vaccines available months earlier than would have been possible under normal circumstances.

Read
Monday, Aug. 23, 2021